Literature DB >> 19705413

Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.

Yu-Hwa Huang1, Alla L Zozulya, Christian Weidenfeller, Imke Metz, Dorothea Buck, Klaus V Toyka, Wolfgang Brück, Heinz Wiendl.   

Abstract

OBJECTIVE: We have recently described a novel population of natural regulatory T cells (T(reg)) that are characterized by the expression of HLA-G and may be found at sites of tissue inflammation (HLA-G(pos) T(reg)). Here we studied the role of these cells in multiple sclerosis (MS), a prototypic autoimmune inflammatory disorder of the central nervous system (CNS).
METHODS: Sixty-four patients with different types of MS, 9 patients with other neurological diseases, and 20 healthy donors were included in this study. Inflamed brain lesions from 5 additional untreated MS patients were examined. HLA-G(pos) T(reg) were analyzed in the cerebrospinal fluid (CSF) by flow cytometry and in inflammatory demyelinating lesions of MS brain specimens by immunohistochemistry. Functional capacity was accessed and transmigration was determined using an in vitro model of the human blood-brain barrier (BBB).
RESULTS: HLA-G(pos) T(reg) were found enriched in the inflamed CSF of MS patients and in inflammatory demyelinating lesions of MS brain specimens. HLA-G(pos) T(reg) showed a strong propensity to transmigrate across BBB, which was vigorously driven by inflammatory chemokines, and associated with a gain of suppressive capacity upon transmigration. CSF-derived HLA-G(pos) T(reg) of MS patients represented a population of activated central memory activated T cells with an upregulated expression of inflammatory chemokine receptors and exhibiting full suppressive capacity. Unlike natural FoxP3-expressing T(reg), HLA-G(pos) T(reg) derived from peripheral blood were functionally unimpaired in MS.
INTERPRETATION: In MS, HLA-G(pos) T(reg) may serve to control potentially destructive immune responses directly at the sites of CNS inflammation and to counterbalance inflammation once specifically recruited to the CNS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19705413     DOI: 10.1002/ana.21705

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  34 in total

1.  Isoforms of the nonclassical class I MHC antigen H2-Q5 are enriched in brain and encode Qdm peptide.

Authors:  Nora E Renthal; Paula A Guidry; Sharmila Shanmuganad; William Renthal; Iwona Stroynowski
Journal:  Immunogenetics       Date:  2010-10-22       Impact factor: 2.846

Review 2.  Janus head: the dual role of HLA-G in CNS immunity.

Authors:  Yu-Hwa Huang; Laura Airas; Nicholas Schwab; Heinz Wiendl
Journal:  Cell Mol Life Sci       Date:  2010-11-18       Impact factor: 9.261

Review 3.  Emerging topics and new perspectives on HLA-G.

Authors:  Enrico Fainardi; Massimiliano Castellazzi; Marina Stignani; Fabio Morandi; Gwenaëlle Sana; Rafael Gonzalez; Vito Pistoia; Olavio Roberto Baricordi; Etienne Sokal; Josè Peña
Journal:  Cell Mol Life Sci       Date:  2010-11-16       Impact factor: 9.261

Review 4.  CD8(+) Tregs in autoimmunity: learning "self"-control from experience.

Authors:  Sue Tsai; Xavier Clemente-Casares; Pere Santamaria
Journal:  Cell Mol Life Sci       Date:  2011-06-14       Impact factor: 9.261

Review 5.  Tregs and infections: on the potential value of modifying their function.

Authors:  Sharvan Sehrawat; Barry T Rouse
Journal:  J Leukoc Biol       Date:  2011-09-13       Impact factor: 4.962

6.  Analysis of Lymphocyte Extravasation Using an In Vitro Model of the Human Blood-brain Barrier.

Authors:  Andreas Schulte-Mecklenbeck; Urvashi Bhatia; Tilman Schneider-Hohendorf; Nicholas Schwab; Heinz Wiendl; Catharina C Gross
Journal:  J Vis Exp       Date:  2017-04-05       Impact factor: 1.355

Review 7.  Impact of HLA-G analysis in prevention, diagnosis and treatment of pathological conditions.

Authors:  Daria Bortolotti; Valentina Gentili; Antonella Rotola; Enzo Cassai; Roberta Rizzo; Dario Di Luca
Journal:  World J Methodol       Date:  2014-03-26

8.  Intrathecal soluble HLA-E correlates with disease activity in patients with multiple sclerosis and may cooperate with soluble HLA-G in the resolution of neuroinflammation.

Authors:  Fabio Morandi; Consuelo Venturi; Roberta Rizzo; Massimiliano Castellazzi; Eleonora Baldi; Maria Luisa Caniatti; Maria Rosaria Tola; Enrico Granieri; Enrico Fainardi; Antonio Uccelli; Vito Pistoia
Journal:  J Neuroimmune Pharmacol       Date:  2013-04-28       Impact factor: 4.147

9.  A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01.

Authors:  Bruce A C Cree; John D Rioux; Jacob L McCauley; Pierre-Antoine F D Gourraud; Philippe Goyette; Joseph McElroy; Philip De Jager; Adam Santaniello; Timothy J Vyse; Peter K Gregersen; Daniel Mirel; David A Hafler; Jonathan L Haines; Margaret A Pericak-Vance; Alastair Compston; Stephen J Sawcer; Jorge R Oksenberg; Stephen L Hauser
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

10.  Temporal pattern of ICAM-I mediated regulatory T cell recruitment to sites of inflammation in adoptive transfer model of multiple sclerosis.

Authors:  Sebastian Doerck; Kerstin Göbel; Gesa Weise; Tilman Schneider-Hohendorf; Michael Reinhardt; Peter Hauff; Nicholas Schwab; Ralf Linker; Mathias Mäurer; Sven G Meuth; Heinz Wiendl
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.